MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

about

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

Item

http://www.wikidata.org/entity/Q51075372

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@en

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@nl

type

Item

label

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@en

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@nl

prefLabel

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@en

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@nl

P1476

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.

@en

P2093

Jue Wei

http://www.w3.org/2001/XMLSchema#string

Ling Xu

http://www.w3.org/2001/XMLSchema#string

Rongrong Jia

http://www.w3.org/2001/XMLSchema#string

Ting Wang

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA Processing and Human Cancer

Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.

Global cancer statistics, 2012

Hepatocellular carcinoma

MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.

Gene-microRNA network module analysis for ovarian cancer.

Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis

Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.

P304

383-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ABBS/GMX017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28369267

http://www.w3.org/2001/XMLSchema#string